Solid science rather than hopeful media reports and advocacy campaigns should determine whether patients receive access to a new, as-yet unproven therapy for multiple sclerosis, according to an editorial in the Canadian Medical Association Journal.
Patients and advocacy groups across the country have been lobbying for access to the venous angioplasty procedure, also dubbed “the liberation therapy,” in the wake of a 2009 study that suggested it held promise to relieve the disease’s debilitating symptoms.... [Read More]